134 related articles for article (PubMed ID: 12145342)
1. Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.
Dohán O; Gavrielides MV; Ginter C; Amzel LM; Carrasco N
Mol Endocrinol; 2002 Aug; 16(8):1893-902. PubMed ID: 12145342
[TBL] [Abstract][Full Text] [Related]
2. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.
De la Vieja A; Ginter CS; Carrasco N
Mol Endocrinol; 2005 Nov; 19(11):2847-58. PubMed ID: 15976004
[TBL] [Abstract][Full Text] [Related]
4. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of V59E NIS, a Na+/I- symporter mutant that causes congenital I- transport defect.
Reed-Tsur MD; De la Vieja A; Ginter CS; Carrasco N
Endocrinology; 2008 Jun; 149(6):3077-84. PubMed ID: 18339708
[TBL] [Abstract][Full Text] [Related]
6. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter.
Zhang Z; Liu YY; Jhiang SM
J Clin Endocrinol Metab; 2005 Nov; 90(11):6131-40. PubMed ID: 16105966
[TBL] [Abstract][Full Text] [Related]
7. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
8. Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter.
Wu SL; Ho TY; Liang JA; Hsiang CY
J Endocrinol; 2008 Nov; 199(2):213-9. PubMed ID: 18708479
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS).
Paroder-Belenitsky M; Maestas MJ; Dohán O; Nicola JP; Reyna-Neyra A; Follenzi A; Dadachova E; Eskandari S; Amzel LM; Carrasco N
Proc Natl Acad Sci U S A; 2011 Nov; 108(44):17933-8. PubMed ID: 22011571
[TBL] [Abstract][Full Text] [Related]
10. The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species.
Selmi-Ruby S; Watrin C; Trouttet-Masson S; Bernier-Valentin F; Flachon V; Munari-Silem Y; Rousset B
Endocrinology; 2003 Mar; 144(3):1074-85. PubMed ID: 12586784
[TBL] [Abstract][Full Text] [Related]
11. Perchlorate transport and inhibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L.
Cianchetta S; di Bernardo J; Romeo G; Rhoden KJ
Toxicol Appl Pharmacol; 2010 Mar; 243(3):372-80. PubMed ID: 20005887
[TBL] [Abstract][Full Text] [Related]
12. Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).
Li W; Nicola JP; Amzel LM; Carrasco N
FASEB J; 2013 Aug; 27(8):3229-38. PubMed ID: 23650190
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect.
Kosugi S; Bhayana S; Dean HJ
J Clin Endocrinol Metab; 1999 Sep; 84(9):3248-53. PubMed ID: 10487695
[TBL] [Abstract][Full Text] [Related]
14. The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane.
Martín M; Salleron L; Peyret V; Geysels RC; Darrouzet E; Lindenthal S; Bernal Barquero CE; Masini-Repiso AM; Pourcher T; Nicola JP
FASEB J; 2021 Aug; 35(8):e21681. PubMed ID: 34196428
[TBL] [Abstract][Full Text] [Related]
15. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients.
Kosugi S; Inoue S; Matsuda A; Jhiang SM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3373-6. PubMed ID: 9745458
[TBL] [Abstract][Full Text] [Related]
16. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD.
Szinnai G; Kosugi S; Derrien C; Lucidarme N; David V; Czernichow P; Polak M
J Clin Endocrinol Metab; 2006 Apr; 91(4):1199-204. PubMed ID: 16418213
[TBL] [Abstract][Full Text] [Related]
17. A novel peculiar mutation in the sodium/iodide symporter gene in spanish siblings with iodide transport defect.
Kosugi S; Okamoto H; Tamada A; Sanchez-Franco F
J Clin Endocrinol Metab; 2002 Aug; 87(8):3830-6. PubMed ID: 12161518
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the mouse sodium iodide symporter.
Pinke LA; Dean DS; Bergert ER; Spitzweg C; Dutton CM; Morris JC
Thyroid; 2001 Oct; 11(10):935-9. PubMed ID: 11716040
[TBL] [Abstract][Full Text] [Related]
19. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
[TBL] [Abstract][Full Text] [Related]
20. Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity.
Li CC; Ho TY; Kao CH; Wu SL; Liang JA; Hsiang CY
J Biomed Sci; 2010 Nov; 17(1):89. PubMed ID: 21092238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
